RCHN..TOP 10 Reasons you should have RCHN in your portfolio
Drum roll please,
No 10
Three sales channels
Industrial
Retail through 3rd parties
Company website
No 9
Growing revs
over 100% y/o/y growth from company website
Industrial sales - Guidance of 30% growth this year
Retail sales - A bunch of new products released in 2nd q
Retail products:
One new product was released during the period ending March 31st, 2012: the MP35X2 dual pump; it was met with excellent reviews by the press, and sold out as soon as released. Demand is expected to remain strong for the product.
A host of new products including but not limited to those listed below are scheduled for release during the second quarter of 2012; the following products have already been discussed in various public forums, and are disclosed hereafter:
? Liquid cooling solutions for AMD Radeon high-end graphics cards:
o Komodo HD7970: released 4-6-2012
o Komodo HD7950" scheduled for release on 5/25/2012
o Heatsinks for various models from 7900 to 7800 series: scheduled fro release throughout June 2012
? Lok-Seal™ complete line of compression fittings: released 4-13-2012
? Helix™ 120mm fan : released 5-1-2012
? Apogee™ Drive II integrated pump and water-block scheduled for release on 5/20/2012
? MCRX40 140mm radiators, scheduled for release on 5/25/2012
? Maelstrom™ integrated pump and 5 ¼" bay reservoir, scheduled for release in June
"Industrial sales are expected to increase 30% from 2011, or about $250k, with most already secured by existing or firmly scheduled purchase orders."
No 8
Shrinking costs
Several cost saving measures in place including.
Improvements in the Production Tools: Investments were made in machinery to increase and diversify the issuer’s production capacity, and to reduce its reliance on sub-contractors for the production of its non-core technology components. The majority of the equipment was purchased late during the year, and is expected to be operational by the end of the first quarter of 2011. Successful utilization of the new production equipment will rely on the recruitment of qualified operators, and depending on this factor the full benefits may not be felt until the third quarter of 2011. Such benefits -should they occur as expected, will result in substantial cost reductions, thus increased competitiveness in sectors where the issuer is currently subcontracting its production. At the current activity level, additional capital requirements in the amount of approximately $150,000 or more are needed to reach full independence for the production of the company’s non-core components. The issuer is dependent upon its ability to raise additional debt or equity capital to finance these purchases.
Improvement in strategic control of the company’s core products: Substantial progress at the R&D level was accomplished in this area, and the issuer is in the final stages of developing one of its core-technology components. If successfully implemented, the technology is expected to reduce the issuer’s current costs by a factor of 3, and to result in substantially improving the issuer’s competitive advantage in the high-volume sectors of its liquid cooling business.
Short term debt: In 2011, Rouchon Industries terminated its factoring accounts receivable line of credit with a factoring limit of $250,000 due to excessive cost in interest expenses ($53K for the year); it was replaced by a Bank revolving line of credit with a limit of $350,000 with interest at the bank prime rate + 1.75%/year (5% at the current rate). This new financing arrangement provides greater borrowing flexibility, a higher credit line, and a substantially lower cost of financing.
Also whatever they were paying Agoracom to provide shareholder exposure is no longer a factor.
NO 7
Growing profit margins.
Previously mentioned cost savings and the fact that they do their own R and D and own their own manufacturing plant saves them a lot of costs and will contribute to greater profit margins. Not all of the measures are in place yet but seasonally slow and before the new products 1st Q showed a 23% increase in revs with only a 1% increase in COGS.
NO 6
Connection to big names players
Not only do their customers include Fortune 500 clients, they also have connections with AMD, NVIDIA and EVGA. possibly others I am unaware of.
NO 5
The best microcap stock website I have ever seen.
Lists all of the products, announces new releases every time there is a new product and awards recd, shows all of the resell distributors they use, user friendly for purchasing direct from manufacturer, with full product descriptions, technical help and even a forum to ask questions. The investor relations page is full of useful info as well.
NO 4
A great management team
http://www.swiftech.com/management.aspx
NO 3
A fantastic share structure
Stable share structure, the company's has 22,505,712 shares outstanding and has not issued any additional shares since before 2008 and a float of 4.3 mil.
NO 2
DEBT FREE
NO 1
China expansion
China Klaus is comin! Lot's of potential customers there.
Another significant factor in the company’s ability to expand into new markets was the completion in 2010 of the registration process of its subsidiary Swiftech Technology (Shenzhen) Co., Ltd. Whereas this fact gives the issuer the ability to sell its products in the high growth consumer market of the PRC, implementation was slower than anticipated because of the manufacturing efforts that took place in 2011, and is thus expected to begin in the second half of 2012.
Summary:
Already profitable with Growing revs, tons of new products being released this q, shrinking costs, larger profit margins, expansion into China, a great share structure, and super products.
Here is an article on liquid cooling: The wave of the present.
http://www.datacenterjournal.com/facilities/l...e-present/
and now
Awareness is spreading.
RCHN..TOP 10 Reasons you should have RCHN in your portfolio
Top 10 Most Recent News Articles
Apotex Enters U.S. Market with Axitinib Tablets Launch
Apotex's Bold Move: Axitinib Tablets Hit the U.S. Market Apotex is shaking things up in the pharma world by launching the first generic version of Axitinib Tablets in the U.S., aimed at treating advanced renal cell carcinoma (RCC) when previous treatments have fallen flat. This isn't just another dance with the red tape—it's a major step for Apotex, flexing their muscle...
Continue Reading
Hermes AI: A New Era in Market Analysis?
Revolution or Just Another App? In a world where stock market insights are as cryptic as hieroglyphs to the average Joe, here comes the Hermes AI Analyzer, breaking onto the scene and promising to translate Wall Street's complex lingo into plain, simple language. It's the brainchild of Turkish engineer Umut Tugrul, who has spent decades in the trenches of software...
Continue Reading
SahajMobile's $25M Boost: Impact on Bangladesh Market
Untapped Digital Frontier in Bangladesh There's an undeniable buzz around SahajMobile's recent $25 million credit facility, and it's one worth dissecting. This shot of capital, lined up with ALMA as part of SahajMobile’s Series A gamble, is setting the stage for a real shuffle in Bangladesh's digital landscape. Plugging into a Market Gap Ever since it hit the ground...
Continue Reading
Ballard's Q3 2026: Navigating Losses and Bold Moves
Ballard’s Financial Puzzles in Q3 2026 Riding the rough waters of the third quarter in 2026, Ballard Power Systems set out its stall with some eyebrow-raising numbers. This ain't the bustling diner vibe we normally see for a thriving business. The results paint a cautious picture sprinkled with strategic shifts that demand a keen eye. GeoPura Acquisition: A Strategic...
Continue Reading
Sinch Appoints Jonas Dahlberg as New CEO: A Strategic Move
A Change at the Helm: Dahlberg Takes Charge Here we go, folks—Sinch, that global powerhouse in customer communications, just got itself a new captain. Jonas Dahlberg is now officially the CEO, after warming the acting CEO seat since June. This ain't your ordinary office shuffle. It's a calculated chess move in the high-stakes tech world. Dahlberg's Path to the Top This...
Continue Reading
Priceline's Cyber Week: A Pocket-Friendly Travel Bonanza
Unpacking Priceline's Cyber Week Bonanza Alright, folks, grab your booking hats because Priceline is back with its annual Cyber Week extravaganza, aiming to give travelers a shot in the arm of savings just when inflation has everyone pinching pennies. From November 16 through December 2, Priceline rolls out the red carpet for vacation planners, offering eye-popping...
Continue Reading
SwitchBot's Hub 4: A Step Toward a Connected Future
Turning a House Into a Smart Home Haven Out of Tokyo and onto the world stage, SwitchBot's got something new cooking that might just shake up the smart home scene. They've launched the Hub 4, a gadget that's like the Swiss Army knife of home control. For those who like things simple, this is a one-hub-to-rule-them-all kind of deal. 101,000 Reasons to Notice Now, they...
Continue Reading
NEDHSA Amplifies Tobacco-Free Push with 2026 Smokeout
2026 Great American Smokeout: A Fresh Push Against Tobacco NEDHSA is sticking to its guns with a tobacco-free campaign that’s got deep roots. The 2026 Great American Smokeout, on November 19, not only highlights past efforts but looks to stir more folks into healthier habits. Beyond the campaign glitz, it’s about dragging a century-long bad habit further into the...
Continue Reading
Veterans Find a Haven in Home Helpers® Franchise
Veterans Thriving at Home Helpers® Tossing out a warm welcome to fresh horizons post-military, Home Helpers® Home Care is serving up more than just compassionate care—it’s become a bonafide haven for veterans diving into the world of franchising. This isn’t just an indie pat on the back; according to the latest scoop from Franchise Business Review, Home Helpers®...
Continue Reading
Trades Workforce Shortage Costs Wallop U.S. Economy
The Forgotten Backbone of America Don't sleep on this: America's got itself a trade worker crisis, and it's not just a numerical hiccup. We’re down nearly 1.9 million skilled trades workers, and that's a gut punch to the economy—a hefty $1.2 billion a day in GDP loss. These are the folks who keep the wheels greased, the lights on, and the goods flowing. Without them,...
Continue ReadingTop 5 Most Recently Viewed Articles
Navigating the Growth of the Digital Signage Market Today
The digital signage market was transforming fast, with projections showing a jump from USD 20.1 billion in 2024 to around USD 27.3 billion by 2029—talk about a solid compound annual growth rate of 6.3%. Traders were buzzing over the factors driving this upward trend: high-res displays and expanding infrastructure in emerging markets had everyone seeing green. Market...
Continue Reading
Exploring the Potential of Healthcare Stocks Amid Market Growth
The stock market is navigating through exciting times, with the S&P 500 recently eclipsing the significant milestone of 5,700 points. This robust performance is fueled by a dynamic shift as investors increasingly look towards emerging sectors, particularly healthcare, which is gaining momentum this earnings season. This year, we've seen an impressive trend, with over 40...
Continue Reading
Recognizing Excellence: Nominate for the Paralegal of the Year Award
Nominations Now Open for the 2025 AAJ Paralegal of the Year Award The American Association for Justice (AAJ) proudly announces that nominations for the 2025 Paralegal of the Year Award are now open. This award, sponsored by Advocate Capital, Inc., is a wonderful opportunity to acknowledge and applaud the significant contributions of paralegals within our civil justice...
Continue Reading
Mavsign and RouteOne Revolutionize Automotive Deal Processes
Mavsign and RouteOne Transforming Automotive Transactions Mavsign, renowned for its expertise in remote document signings and compliance solutions, has announced an exciting partnership with RouteOne, a leader in automotive financing solutions. This collaboration aims to enhance the efficiency and security of automotive transactions by integrating both companies'...
Continue Reading
Revance Stockholders Encouraged to Support Crown's Tender Offer
Crown's Tender Offer for Revance Stock: Key Information Revance Therapeutics, Inc. (NASDAQ: RVNC) stockholders are being urged to support Crown Laboratories, Inc. by tendering their shares before the upcoming deadline. This is an important moment as Crown's tender offer presents the only current proposal post Teoxane's withdrawal. Details of the Crown Offer Crown has made...
Continue Reading